 |
 |
 |
About Us ReCor Medical is developing an investigational device that is intended to provide a transcatheter treatment for mitral valve insufficiency (regurgitation). Mitral valve insufficiency is an important risk factor and component of congestive heart failure. 22 million people world-wide suffer from congestive heart failure. Surgical mitral valve repair or replacement remains an important part of the work of cardiac surgery centers. 45% of patients with congestive heart failure are not fit for surgery so there is an evident clinical need for a less invasive therapy. For information, please contact us at: |
 |